Mind Medicine (MindMed) - 4 Year Stock Price History | MNMD

The latest closing stock price for Mind Medicine (MindMed) as of November 08, 2024 is 8.49.

  • An investor who bought $1,000 worth of Mind Medicine (MindMed) stock at the IPO in 2020 would have $10,320 today, roughly 10 times their original investment - a 62.47% compound annual growth rate over 5 years.
  • The all-time high Mind Medicine (MindMed) stock closing price was 68.55 on April 28, 2021.
  • The Mind Medicine (MindMed) 52-week high stock price is 12.22, which is 43.9% above the current share price.
  • The Mind Medicine (MindMed) 52-week low stock price is 2.41, which is 71.6% below the current share price.
  • The average Mind Medicine (MindMed) stock price for the last 52 weeks is 6.51.
For more information on how our historical price data is adjusted see the Stock Price Adjustment Guide.

Mind Medicine (MindMed) - 4 Year Stock Price History | MNMD

  • An investor who bought $1,000 worth of Mind Medicine (MindMed) stock at the IPO in 2020 would have $10,320 today, roughly 10 times their original investment - a 62.47% compound annual growth rate over 5 years.
  • The all-time high Mind Medicine (MindMed) stock closing price was 68.55 on April 28, 2021.
  • The Mind Medicine (MindMed) 52-week high stock price is 12.22, which is 43.9% above the current share price.
  • The Mind Medicine (MindMed) 52-week low stock price is 2.41, which is 71.6% below the current share price.
  • The average Mind Medicine (MindMed) stock price for the last 52 weeks is 6.51.
For more information on how our historical price data is adjusted see the Stock Price Adjustment Guide.
Related Stocks
Company NameMarket
Cap
Amgen (AMGN)$174.8B
Vertex Pharmaceuticals (VRTX)$133.1B
Gilead Sciences (GILD)$120.2B
Bristol Myers Squibb (BMY)$109.8B
Regeneron Pharmaceuticals (REGN)$91B
CSL (CSLLY)$90.5B
GSK (GSK)$75.2B
Alnylam Pharmaceuticals (ALNY)$35.8B
Argenex SE (ARGX)$35.6B
BioNTech SE (BNTX)$26.3B
Biogen (BIIB)$25.2B
Illumina (ILMN)$24B
BeiGene (BGNE)$20B
Moderna (MRNA)$18B
Incyte (INCY)$16.1B
Genmab (GMAB)$15.3B
Vaxcyte (PCVX)$13.3B
Insmed (INSM)$13.2B
BioMarin Pharmaceutical (BMRN)$12.8B
Bio-Techne Corp (TECH)$12.1B
Sarepta Therapeutics (SRPT)$11.6B
Exelixis (EXEL)$10.4B
Revolution Medicines (RVMD)$10.2B
QIAGEN (QGEN)$10B
Intra-Cellular Therapies (ITCI)$9.7B
Exact Sciences (EXAS)$9.5B
Bio-Rad Laboratories (BIO.B)$9.4B
Roivant Sciences (ROIV)$8.8B
Repligen (RGEN)$7.9B
Halozyme Therapeutics (HALO)$7.8B